Stocklytics Platform
Asset logo for symbol MCK
McKesson
MCK62
$692.27arrow_drop_down0.41%-$2.89
S&P500
Asset logo for symbol MCK
MCK62

$692.27

arrow_drop_down0.41%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

McKesson (MCK) Stocklytics Forecast

McKesson Corp (MCK) is a well-established company in the healthcare industry, providing pharmaceuticals and medical supplies to hospitals, pharmacies, and other healthcare providers. As with any stock prediction, it's important to note that forecasting future prices is inherently uncertain and subject to various factors. However, analysts and AI algorithms can provide insights based on historical data and market trends.
According to analysts' price target projections, McKesson Corp (MCK) has a positive outlook for the future. The average price target for MCK stock is expected to increase over the next few years, reaching a target price of $200 by 2023. This projection takes into consideration factors such as the company's financial performance, industry trends, and potential growth opportunities.
add McKesson to watchlist

Keep an eye on McKesson

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the AI price prediction for McKesson (MCK) stock?

At present, there is no AI or machine-learning-based price prediction available for McKesson (MCK) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.
help

What is the analyst price prediction for McKesson (MCK) stock?

Analysts have set a target price of $539.43 for McKesson (MCK), based on forecasts from 28 analysts. The predicted price range extends from a high of $671 to a low of $427. This represents a potential increase of up to -3.07% and a decrease of -38.32% from the current price of $692.27. These forecasts are as of 2023 May 09.
help

What are the analyst ratings for McKesson (MCK) stock?

The analyst ratings for McKesson (MCK) are distributed as follows: 13 analysts recommend buying, 3 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 17 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering McKesson.

Take Your Investments to a Whole New Level